Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
US FDA Asks Sponsors Of Discontinued Naloxones To Consider Return To Market
Jul 09 2019
•
By
Derrick Gingery
US FDA wants to increase the availability of naloxone, which is used for emergency opioid overdoses. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Generics
More from Biosimilars & Generics